Allred Capital Management, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allred Capital Management, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$33,345
-74.2%
253,0000.0%0.02%
-73.0%
Q2 2023$129,030
+0.9%
253,000
+24.6%
0.06%
-7.4%
Q1 2023$127,890
+2.1%
203,000
+5.2%
0.07%
-1.4%
Q4 2022$125,276
-53.8%
193,000
+22.2%
0.07%
-59.2%
Q3 2022$271,000
+43.4%
158,000
+3.3%
0.17%
+42.0%
Q2 2022$189,000
+127.7%
153,000
+19.5%
0.12%
+170.5%
Q1 2022$83,000
-25.9%
128,000
+24.3%
0.04%
-18.5%
Q4 2021$112,000
+16.7%
103,000
+94.3%
0.05%
+8.0%
Q3 2021$96,000
+14.3%
53,000
+65.6%
0.05%
+19.0%
Q2 2021$84,000
-99.9%
32,000
+18.5%
0.04%
-4.5%
Q1 2021$97,200,000
+142841.2%
27,0000.0%0.04%
+18.9%
Q4 2020$68,000
-6.8%
27,000
-7.7%
0.04%
-15.9%
Q3 2020$73,000
-7.6%
29,250
+20.6%
0.04%
-12.0%
Q2 2020$79,000
+14.5%
24,250
-14.2%
0.05%
-7.4%
Q1 2020$69,000
-99.9%
28,250
+17.7%
0.05%
-12.9%
Q4 2019$113,280,000
+128627.3%
24,000
+11.6%
0.06%
+17.0%
Q3 2019$88,000
-24.1%
21,5000.0%0.05%
-19.7%
Q2 2019$116,000
+34.9%
21,5000.0%0.07%
+34.7%
Q1 2019$86,000
+115.0%
21,5000.0%0.05%
+81.5%
Q4 2018$40,00021,5000.03%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders